Poseida Therapeutics (PSTX) Earnings Date & Reports

A.I. Advisor

published Earnings

PSTX is expected to report earnings to rise 21.22% to -38 cents per share on November 07

Poseida Therapeutics PSTX Stock Earnings Reports

Q3'24

Est.

$-0.39

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.17

Q4'23

Beat

by $0.12

Q3'23

Missed

by $0.06

The last earnings report on August 05 showed earnings per share of -31 cents, beating the estimate of -40 cents. With 808.40K shares outstanding, the current market capitalization sits at 281.69M.

View a ticker or compare two or three

Compare

PSTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PSTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

9390 Towne Centre Drive

Phone

+1 858 779-3100

Employees

330

Web

https://www.poseida.com